metricas
covid
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 18F-DCFPyL PET/CT guidelines
Journal Information
Vol. 42. Issue 3.
Pages 203-208 (May - June 2023)
Share
Share
Download PDF
More article options
Visits
47
Vol. 42. Issue 3.
Pages 203-208 (May - June 2023)
Special collaboration
18F-DCFPyL PET/CT guidelines
Guía del procedimiento de la PET/TC con 18F-DCFPyL
Visits
47
A.L. Gutiérrez Cardoa, J.A. Vallejo Casasb, J.R. García Garzónc, J.L. Tirado Hospitald, R. Medina Lópeze, J.M. Freire Macíasf, A. Rodríguez Fernándezg,
Corresponding author
a Servicio de Medicina Nuclear, Hospital Regional de Málaga, Málaga, Spain
b Servicio de Medicina Nuclear, Hospital Universitario Reina Sofía, Córdoba, Spain
c Servicio de Medicina Nuclear, Cetir-Ascires, Barcelona, Spain
d Servicio de Medicina Nuclear, Hospital Universitario Virgen del Rocío, Sevilla, Spain
e Unidad de Nefrourología, Hospital Universitario Virgen del Rocío, Sevilla, Spain
f Servicio de Medicina Nuclear, Hospital Universitario Puerta del Mar, Cádiz, Spain
g Servicio de Medicina Nuclear, Hospital Universitario Virgen de las Nieves, Granada, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (3)
Table 1. Summary of findings with confidence score.
Table 2. Study characteristics.
Table 3. Systematic description of the findings.
Show moreShow less
Abstract

The objective of this guide is to provide to nuclear medicine physicians a tool based on scientific evidence and prepared by consensus of experts, to perform the 18F-DCFPyL PET/CT procedure with safely and efficiently for patients with prostate cancer who present PSMA overexpression.

For them, some recommendations will be established for 18F-DCFPyL PET/CT examination: reconstruction parameters, presentation of the images and their interpretation. The possible false positives of the procedure will be analysed, how to interpret them and how to avoid them.

Finally, all exploration should lead to the preparation of a report that answers the clinician’s question. For this, it is recommended to prepare a structured report that includes the PROMISE criteria as well as the classification of the findings according to PSMA-RADS parameters.

Keywords:
Guidelines
Prostate cancer
PET/CT
DCFPyL
Resumen

Esta guía tiene como objetivo facilitar al médico nuclear una herramienta basada en la evidencia científica, y elaborada por consenso de expertos para realizar el procedimiento PET/TC con 18F-DCFPyL de modo seguro y eficiente para el paciente con cáncer de próstata que presenta sobreexpresión del PSMA.

Para ellos se establecerán unas recomendaciones para la realización de la exploración PET/TC con 18F-DCFPyL, parámetros de reconstrucción, presentación de las imágenes e interpretación de las mismas. Se analizarán los posibles falsos positivos de la exploración, como interpretarlos y cómo evitarlos.

Finalmente, toda exploración debe conducir a la elaboración de un informe que de respuesta a la pregunta del clínico. Para ello se recomienda realizar un informe estructurado en el que se incluyan los criterios PROMISE, así como la clasificación de los hallazgos según parámetros PSMA-RADS.

Palabras clave:
Guía
Cáncer de próstata
PET/TC
DCFPyL

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.remnie.2024.500045
No mostrar más